Exogenous glycation
Exogenous glycation or glycation occurs when proteins are cooked with sugars. Temperatures above 120 °C favour this process. Biochemically, this is the multi-stage process of the so-called Maillard reaction with the intermediate step of forming Schiff bases. The reaction product, the AGEs (Advanced Glycation Endproducts) are used in the food industry as flavour enhancers or as colouring agents.
Endogenous Glycation
With endogenous glycation in the organism, as with exogenous glycation) sugar molecules (especially fructose, galactose and glucose) react with the body's own proteins without catalytic enzyme involvement. During this chemical reaction, bioactive molecules (e.g. dicarbonyls such as 3-deoxyglucosone and methylglyoxal) are formed as AEGs, which are progressively deposited and accumulate in the tissue with increasing age. They thus have an influence on intrinsic skin aging. The concentration of AGEs depends on the sugar supply. Endogenous AGE formation is intensified by oxidative stress and chronic inflammation. AGEs are considered a strong independent predictive factor for arteriosclerosis, especially in diabetics and haemydialysis patients.
Among the diagnostically important AGEs is HbA1, which is formed during the glycation of hemoglobin and whose concentration plays an important diagnostic role in assessing average blood glucose levels.
Some AGEs promote inflammatory processes, sometimes by binding to a cellular receptor "Receptor for AGE (RAGE)" on monocytes. In neurons, glycation can lead to degenerative degradation of myelin and neuropathies. This process plays a role in diabetes mellitus type II and Alzheimer's disease.